DIAGNOSTICS DEVELOPMENT HUB (DXD)
As part of the Innovation Cluster Programme funded by the National Research Foundation (NRF), the Diagnostics Development (DxD) Hub is a national initiative led by A*ccelerate (previously known as ETPL) with the aim to accelerate the transformation of IPs into clinically validated diagnostic devices that are ready for market adoption.
Through impactful diagnostics products, we hope to contribute to the development of an effective diagnostics devices ecosystem in Singapore, by empowering local start-ups and SMEs, and also anchoring global companies in Singapore.
The DxD Hub’s initial focus will be diagnostics sub-segments with high growth potential like immunochemistry, point-of-care devices and molecular diagnostics, developing products addressing strategic global indications dealing with the Asian phenotype. In the development of its products, the Hub will work closely with Singapore’s clinical community to tap on its strengths, and also to address pertinent clinical unmet needs.
- Regulatory navigation and dossier preparation
- ISO13485 product design and development
- Design optimisation and verification
- Clinical validation